A process for producing an artificial skin, characterized by adding a matrix metalloprotease inhibitor and a heparanase inhibitor to a culture medium for artificial skin formation purposes which contains keratinocytes derived from a human epidermis and fibroblasts derived from a human dermis and culturing the cells contained in the culture medium, thereby forming the artificial skin.
